The drug trying to tackle sexual desire

The Washington Post
  • 9 years ago
In August, the FDA approved flibanserin, also known as Addyi, for premenopausal women diagnosed with sexual desire dysfunction. Here's how it works and why some are calling it a game changer.

Recommended

1:52
I
Up next
Clinton campaign tells supporters 'head home ... get some sleep'
The Washington Post
1:59
Who is Sarah Huckabee Sanders?
The Washington Post
3:58
T.D. Jakes on the power of instinct vs. intellect | On Faith
The Washington Post
2:01
5 strategies to raise moral, kind children
The Washington Post
2:33
Glenelg advances in the playoffs with a dominant 38-7 win over River Hill
The Washington Post
2:28
A senator's long fight to show the science on climate change is 'mixed'
The Washington Post
0:49
Heavy rain floods Southern California streets
The Washington Post
1:56
These are the Amy Schumer jokes people say are racist
The Washington Post
2:30
Take a ride on a virtual reality roller coaster
The Washington Post
2:50
Le Pen and Macron to face off in French election runoff
The Washington Post
2:10
The British Parliament spent 3 hours pummeling Donald Trump
The Washington Post
0:14
Syrian refugees: Mauneer Kalthoum
The Washington Post
12:05
What you may not have known about JFK's last days
The Washington Post
8:26
MacNeil: 'I saw Jackie Kennedy come out with a coffin'
The Washington Post

Featured channels

More from
SportsGrid
More from
AccuWeather
More from
Forbes Breaking News
More from
Delish
More from
Fortune
More from
NASCAR